- Social Responsibility
- Social Responsibility
- Our Giving
- Corporate Social Responsibility
- Be The First Tobacco-Free Generation
- Community Stories
- Thought Leadership
- Investor Story
- Results Center
- 2016 In Review
- Financial Information
- SEC Filings
- Events & Presentations
- Stock Information
- Corporate Governance
- Investor Resources
CVS Caremark's MinuteClinic to Deploy Allscripts EHR Nationally
Wednesday, February 29, 2012
CHICAGO and WOONSOCKET, R.I., Feb. 21, 2012 /PRNewswire/ -- CVS Caremark's MinuteClinic, the leading retail health clinic in the United States, will transition from its existing, proprietary Electronic Medical Record system to the AllscriptsMyWay Electronic Health Record. This transition will assist MinuteClinic in its mission of delivering high quality accessible medical care in hundreds of retail clinics across the United States.
"MinuteClinic is partnering with Allscripts to assure that we are utilizing the most advanced electronic health record platform in the market," said Andrew Sussman, M.D., president, MinuteClinic and senior vice president/associate chief medical officer, CVS Caremark. "This will help support our nurse practitioners and physician assistants in continuing to meet and exceed the high standards we have set for quality and adherence to practice guidelines."
With Allscripts Electronic Health Record, MinuteClinic becomes part of one of the largest networks of healthcare providers using Electronic Health Records. In addition, Allscripts' current clients include some of the prominent health care systems with which MinuteClinic has affiliated, positioning MinuteClinic well for future growth and clinical collaboration.
"As part of an expanding partnership, we're dedicated to helping MinuteClinic continue its high patient satisfaction rating by enabling seamless, private and reliable access to patient information where and when it's needed and also provide the opportunity to share their treatments electronically with the patient's primary care physician," said Glen Tullman, Chief Executive Officer of Allscripts.
Get Connected with Allscripts at HIMSS
Visit It Takes A Community: The Allscripts Blog to discuss the conference or stop by the Allscripts booth #3016. Follow us on Twitter: @Allscripts or #HIMSS12.
MinuteClinic is a division of CVS Caremark Corporation (NYSE: CVS), the largest pharmacy health care provider in the United States. MinuteClinic launched the first retail walk-in clinics in the United States in 2000 and is the largest provider of walk-in clinics with more than 600 locations in 25 states and the District of Columbia. By creating a health care delivery model that responds to patient demand, MinuteClinic makes access to high quality medical treatment easier for more Americans. Nationally, the company has generated more than 11 million patient visits, with a 95% customer satisfaction rating. MinuteClinic is the first retail health care provider to receive accreditation (2006) reaccreditation (2009) from The Joint Commission, the national evaluation and certifying agency for nearly 15,000 healthcare organizations and programs in the United States. For more information, visit www.MinuteClinic.com.
Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit http://www.allscripts.com/, Twitter, Facebook and YouTube.
Allscripts MyWay with integrated practice management is designed specifically to help providers in independent and small-group practices overcome cost and IT complexity barriers. Available as both an on-premise and cloud-based solution, the EHR enables providers to choose the delivery method that works best for them, and offers robust capabilities for electronic health, practice management and claims management.
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that the expected synergies, efficiencies and cost savings of the merger with Eclipsys Corporation ("Eclipsys") will not be realized, or will not be realized within the expected time period; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that the Allscripts and Eclipsys businesses will not be integrated successfully; competition within the industries in which we operate; failure to achieve certification under the Health Information Technology for Economic and Clinical Health Act could result in increased development costs, a breach of some customer obligations and could put us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; the outcome of any legal proceeding that has been or may be instituted against us; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; and breach of our security by third parties. See our Annual Report on Form 10-KT for the seven months ended December 31, 2010 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
Investors, Seth Frank, +1-312-506-1213, email@example.com or Media, Ariana Nikitas, +1-312-506-1236, firstname.lastname@example.org, or Claire Weingarden, +1-312-447-2442, email@example.com, all of Allscripts; or Carolyn Castel, +1-401-770-5717, firstname.lastname@example.org, or Brent Burkhardt, +1-410-986-1303, email@example.com both of MinuteClinic for Allscripts